top of page

8/30 - 9/6 North America Healthcare Market Weekly Report

<Weekly Report>

[1]Health Officials Advise Biden to Scale Back Covid-19 Booster Shots Plan For Now - The New York Times (



[4] When Will the Delta Surge End? - The New York Times (

[5] The W.H.O. lists Mu as a ‘variant of interest.’ - The New York Times (

[6]Pandemic spurs rise of infections contracted at healthcare facilities | Healthcare Dive

[7] Covid-19: Biden Pledges $2.7 Billion to Help Create ‘Arsenal of Vaccines For the World’ - The New York Times (

[8]FDA restarts distribution of Lilly's COVID-19 drug in 22 states | BioPharma Dive

[9] Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims - The New York Times (

[10]Pfizer, Merck launch large new trials of oral COVID-19 drugs | Healthcare Dive

[11] First Biogen, now the FDA: Congressional Democrats request agency records about Aduhelm's approval | FiercePharma

[12]Medicare insolvency still expected by 2026, unchanged by COVID-19, trustees say | Healthcare Dive

[13] With safety worries mounting, FDA limits who can take certain immune-regulating drugs | BioPharma Dive

[14] As New Texas Abortion Ban Takes Effect, Providers Rush to Adjust - WSJ

[15]Hospital lobby urges Congress to extend Medicare cut relief | Healthcare Dive

[16]AHA presents Congress with laundry list of requests for budget reconciliation bill | Healthcare Dive

4 views0 comments
bottom of page